RF Kennedy Jr, Health Secretary, Source: AP
The future of childhood vaccinations in the U.S. is suddenly in question. Health Secretary Robert F. Kennedy Jr.’s newly restructured vaccine advisory committee is set to vote this week in Atlanta on whether to alter long-standing recommendations for several critical vaccines, including shots against chickenpox, measles, mumps, rubella, hepatitis B, and COVID-19.
The committee, known as the Advisory Committee on Immunization Practices (ACIP), plays a powerful role: its recommendations guide pediatricians nationwide and determine which shots are covered by the government-funded Vaccines for Children (VFC) program, a safety net for low-income families.
While some experts say the agenda looks like a routine review, others worry it could open the door to unnecessary confusion, weaken trust, and reduce access to vaccines that have long protected children from serious disease.
Also Read: Unique Symptoms Of Covid In 2025 And How Long Infection Now Last
Before the chickenpox vaccine was licensed in 1995, nearly every American child contracted the disease. While often dismissed as a rite of passage with itchy rashes and mild fevers, chickenpox could also lead to severe complications like pneumonia, skin infections, brain swelling, and in rare cases, death. The virus, varicella, also lingers in the body and can resurface decades later as shingles, a painful nerve condition.
The introduction of the vaccine dramatically reduced cases and hospitalizations. In 2005, regulators approved a combination shot called MMRV, which bundled measles, mumps, rubella, and varicella vaccines into a single injection. Initially, health officials recommended the combo as the preferred option for the first dose in toddlers.
However, studies soon revealed a catch: children who received the MMRV shot were more likely to develop fevers, rashes, and in rare instances, febrile seizures compared with those who got separate MMR and varicella injections.
In response, the ACIP in 2009 updated its guidance, recommending separate shots for the first dose (typically given between ages 12–15 months) but allowing the combo shot for the second dose in preschool years.
Today, most pediatricians follow that approach. Still, the evidence hasn’t changed in over a decade. That raises eyebrows about why the Kennedy-led committee is reopening the debate now.
Public health experts caution that limiting the combined shot could make vaccination less convenient for families and potentially reduce uptake. Pediatric advisors warn that even small barriers, like two shots instead of one, can mean some kids fall behind.
While much of the attention is on chickenpox, the measles, mumps, and rubella (MMR) vaccine remains equally critical. Each of these viruses was once a common threat in childhood:
Before widespread vaccination began in the 1970s, hundreds of thousands of children in the U.S. contracted these diseases every year. Outbreaks have returned in recent years when vaccination rates dip, underscoring the importance of reliable and consistent recommendations.
Revisiting guidance without new evidence, experts say, risks fueling skepticism among parents already facing a flood of misinformation online.
The COVID-19 shots are also on the table. Typically, ACIP renews recommendations annually for vaccines against respiratory viruses such as flu. But this June, Kennedy’s panel endorsed flu vaccines while staying silent on COVID-19.
Also Read: US Health Officials To Examine Covid Vaccine Effects In Pregnant Women And Kids
That silence matters. Earlier, Kennedy had already removed COVID-19 shots from CDC recommendations for healthy children and pregnant women, sparking lawsuits from pediatric groups who said the move endangered kids’ health.
The FDA recently narrowed the authorization of updated COVID-19 vaccines, limiting use for certain younger groups. If ACIP mirrors that without clarification, millions of children could lose federally funded access through the Vaccines for Children program. Experts warn this could leave families confused, especially since COVID-19 formulations update yearly, much like flu shots.
Hepatitis B presents a different set of challenges. The virus can cause chronic liver infection, cirrhosis, and cancer. While adults often acquire it through sexual contact or sharing needles, newborns face the highest lifelong risk if exposed at birth.
Since 2005, U.S. guidance has recommended that infants receive their first hepatitis B shot within 24 hours of birth. This approach significantly reduced cases of mother-to-child transmission, which often slipped through maternal screening programs. Studies show the newborn shot is safe and highly effective, preventing 85–95% of chronic infections.
Yet Kennedy’s committee has floated the idea of revisiting this recommendation, though experts note there is no new evidence suggesting safety concerns. Critics argue that questioning the birth dose now could reverse decades of progress.
Beyond the science, the politics surrounding these deliberations are unusual. Kennedy, once one of the nation’s most vocal vaccine skeptics, dismissed the 17-member ACIP earlier this year and replaced it with a panel that includes several anti-vaccine voices.
Historically, ACIP’s recommendations are based on careful review by subcommittees made up of pediatricians, infectious disease experts, pharmacists, and public health officials. Those subgroups sift through peer-reviewed studies, track outbreaks, and balance risks against benefits. But this time, critics say the process appears less about science and more about ideology.
Even if the committee doesn’t overturn long-standing guidance, simply reopening settled debates may erode confidence. Parents who hear that vaccines are “under review” might delay or decline shots, leaving children vulnerable.
Perhaps most worrisome: a restrictive vote could block coverage of these vaccines under the Vaccines for Children program, which supplies nearly half of all childhood shots in the U.S. Without it, low-income families could lose access, widening gaps in protection.
The stakes of this week’s ACIP votes go far beyond the meeting room in Atlanta. At issue is not just whether a child gets one shot or two, but whether the nation maintains decades of progress against diseases once considered inevitable.
Chickenpox, measles, mumps, rubella, hepatitis B, and COVID-19 vaccines have all proven their worth in protecting children from dangerous, sometimes deadly illnesses. Experts say undermining trust or restricting access now could reopen the door to outbreaks that public health worked so hard to shut.
Credits: iStock
The World Health Organization (WHO) on December 24 prequalified two rapid antigen diagnostic tests (Ag-RDTs) for SARS-CoV-2. This virus is known to have caused COVID-19. As per the WHO, these two tests are called SD Biosensor STANDARD Q COVID-19 Ag Test and the ACON Biotech Flowflex SARS-CoV-2 Antigen Rapid Test (Self-Testing).
At first these tests got temporary emergency approval from the WHO during the pandemic. This was done so the countries could start using them quickly even though long-term data was limited. This emergency approval helped the tests reach over 100 countries when they were urgently needed.
The WHO has now given these tests full prequalification, which means it has a stronger and long-term approval. This means that the WHO has thoroughly checked and confirmed that the tests consistently meet global standards for quality, safety, and accuracy.
Even though WHO officially ended COVID-19 emergency phase over two years ago, the virus is still circulating globally. In fact, this year, we have seen variants of COVID-19 circulating around, causing the most unique symptoms, including razor-blade like throat. Variants like JN.1, Stratus, Nimbus, LP8.1, and BA.3.2 were all that we saw in 2025.
While the good news is that infection levels are relatively stable, but the virus has not completely disappeared and testing is still necessary, especially in poorer countries.
Many low-income countries do not have easy access to labs or expensive PCR testing. So there is still a need for a strong, but cheaper and reliable way to detect COVID-19, and these tests may as well do that.
However, it is important to note that rapid antigen tests are not replacement for PCR tests. They simply complement the PCR tests by allowing faster, on-the-spot decisions, especially when the lab capacity is limited.
Rapid antigen tests could help with spotting and stopping local outbreaks quickly, protecting high-risk people and healthcare workers, and staying prepared for future respiratory pandemics.
The WHO is also pushing for decentralized, quality-checked testing as part of universal healthcare and global health security, so countries aren’t caught unprepared when the next outbreak happens.
If you notice these following symptoms as noted by the Centers for Disease Control and Prevention (CDC), it is best that you get yourself a COVID-19 test:
Credits: iStock
As Delhi's air quality levels and pollution continues to worsen, and people struggle to breathe, countries like Singapore, the United Kingdom, and Canada issued advisories for their citizens travelling to the capital city. However, the capital city's crisis continues to remain ignore, though CM Rekha Gupta did hold a review meeting on the same on Monday, with a follow-up scheduled on Thursday.
Singapore High Commission issued an advisory, which stated:
On 13 December 2025: The Indian Central Pollution Control Board invoked Stage 4, the highest level, of the Graded Response Action Plan (GRAP) in the Delhi National Capital Region. Under GRAP 4, construction and industrial activities are heavily restricted, and schools and offices are encouraged to shift to hybrid format. The Delhi authorities have urged residents to stay indoors, especially children and those with respiratory or cardiac ailments, and to use masks if stepping out. In this regard, the High Commission urges Singapore nationals in the Delhi National Capital Region to pay heed to this advice.
We also note that given the low visibility, flights to and from the Delhi National Capital Region are likely to be affected. The Indira Gandhi International Airport and several airlines have issued advisories. Travellers should take note of this, and check with the respective airlines for updates.
UK's Foreign, Commonwealth & Development Office (FCDO) warned that air pollution could lead to serious health threats for those living in northern India, especially between the months of October and February. The UK advisory also stressed on the health of pregnant women and people with any heart or respiratory. The advisory noted that they must seek medical advice before travelling to India.
The statement read: Children, the elderly and those with pre-existing medical conditions may be especially affected. If you’re pregnant or have a respiratory or heart condition you may wish to consult a medical practitioner before you travel.
Canada too issued a similar notice, advising, especially those who are already struggling with respiratory issues and to continuously monitor air quality levels. The notice also highlighted the pollution that is caused by fog and smoke trends that are increasing in urban areas like Delhi, especially during the winters.
The advisory read: Smoke haze and other types of air pollution can be extremely hazardous in urban areas and cities such as Delhi. It’s typically at its worst in winter. In rural areas, air quality can be affected by agricultural burning. Dust storms also occur across northern India. Monitor air pollution levels, which change quickly, especially if you suffer from respiratory ailments or have pre-existing medical conditions.
As of today, Delhi's air quality remained in "very poor" category, and the AQI stood at 342 at 8am, as per the Central Pollution Control Board. The 24-hour average AQI was logged at 412 under the "severe" category on Tuesday evening when Delhi's quality peaked to record the fourth severe air day in the month of December.
Source: Parkland Fire Company
A Pennsylvania nursing home caught on fire due to an apparent gas explosion. The Silver Lake Nursing home in Pennsylvania's Bristol Township caught on fire, and videos show flames erupting from the building, and debris scattered around the area. The Pennsylvania Governor Josh Shapiro confirmed the that there are so far two deaths, with 21 people found injured. Many have been rescued, yet rescuers believe that five people are unaccounted for.
At 2.15pm is when the flames could be seen from the gas-related explosion. PECO confirmed that crew had started to respond around 2pm itself after they received reports of a gas odor. The explosion had occurred when the crew were on the scene.
“While crews were on site, an explosion occurred at the facility. PECO crews shut off natural gas and electric service to the facility to ensure the safety of first responders and local residents,” the utility said in a the statement.
State Rep. Tina Davis told the Associated Press. "I saw smoke and I saw car after car after car was a fire truck or ambulance from all over the city, from all over."
Davis says that there were talks of using a nearby school as a temporary evacuation area.
Burn injuries are first classified before the treatment. Their classification decides the treatment the burn will require. There are for classifications of burns:
First-degree or superficial burns: They only affect the outer layer of the skin or the epidermis. In these injuries, the burn site is red, painful, dry, and has no blisters.
Second-degree or partial thickness burns: They are only the burns of epidermis and part of the lower layer of the skin, the dermis. The burn site looks red and blistered and may be swollen and painful.
Third-degree or full thickness burns: Third-degree burns destroy the epidermis and dermis. They could also go to the innermost later of the skin, the subcutaneous tissue. The burn site could look white or blackened and charred.
Fourth-degree burns: They burn through both layers of the skin and underlying tissue as well as deeper tissue, and could possibly reach muscle and bone. There is no feeling in the area since the nerve endings are destroyed.
The right way to treat a burn depends on its depth and how much of the body it covers. While minor, superficial burns can be managed at home, deeper or larger burns may need medical attention. Keep these essential guidelines in mind:
© 2024 Bennett, Coleman & Company Limited